These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 25255409

  • 1. Management of hemorrhage with the target-specific oral anticoagulants.
    Pluym M, Howell G.
    Hosp Pract (1995); 2014 Aug; 42(3):75-83. PubMed ID: 25255409
    [Abstract] [Full Text] [Related]

  • 2. Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban.
    Fawole A, Daw HA, Crowther MA.
    Cleve Clin J Med; 2013 Jul; 80(7):443-51. PubMed ID: 23821689
    [Abstract] [Full Text] [Related]

  • 3. [Management of direct action oral anticoagulants in the peri-operative period and invasive techniques].
    Llau JV, Ferrandis R, Castillo J, de Andrés J, Gomar C, Gómez-Luque A, Hidalgo F, Torres LM, participantes en el Foro de Consenso de la ESRA-España sobre «Fármacos que alteran la hemostasia».
    Rev Esp Anestesiol Reanim; 2012 Jul; 59(6):321-30. PubMed ID: 22633209
    [Abstract] [Full Text] [Related]

  • 4. [New oral anticoagulants in venous thromboembolism. General practice information on switching, monitoring, pausing].
    Oberhofer E.
    MMW Fortschr Med; 2015 Jan 19; 157(1):24. PubMed ID: 25743289
    [No Abstract] [Full Text] [Related]

  • 5. Strategies for urgent reversal of target-specific oral anticoagulants.
    Davis EM, Uhlmeyer EM, Schmidt DP, Schardt GL.
    Hosp Pract (1995); 2014 Dec 19; 42(5):108-25. PubMed ID: 25485923
    [Abstract] [Full Text] [Related]

  • 6. New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management. Australasian Society of Thrombosis and Haemostasis.
    Tran H, Joseph J, Young L, McRae S, Curnow J, Nandurkar H, Wood P, McLintock C.
    Intern Med J; 2014 Jun 19; 44(6):525-36. PubMed ID: 24946813
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel oral anticoagulants: efficacy, laboratory measurement, and approaches to emergent reversal.
    Gehrie E, Tormey C.
    Arch Pathol Lab Med; 2015 May 19; 139(5):687-92. PubMed ID: 25927153
    [Abstract] [Full Text] [Related]

  • 13. [Clinical pharmacological aspects of new oral anticoagulants].
    Haschke M.
    Ther Umsch; 2012 Nov 19; 69(11):657-60. PubMed ID: 23117669
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Managing new oral anticoagulants in the perioperative and intensive care unit setting.
    Levy JH, Faraoni D, Spring JL, Douketis JD, Samama CM.
    Anesthesiology; 2013 Jun 19; 118(6):1466-74. PubMed ID: 23416382
    [Abstract] [Full Text] [Related]

  • 16. [Laboratory diagnostic with regard to new anticoagulants - monitoring and influence on coagulation tests].
    Nagler M, Wuillemin W.
    Ther Umsch; 2012 Nov 19; 69(11):650-6. PubMed ID: 23117668
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The novel anticoagulants: the surgeons' prospective.
    Shamoun FE, Martin EN, Money SR.
    Surgery; 2013 Mar 19; 153(3):303-7. PubMed ID: 23218887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.